OTC · Biotechnology

Oxford Nanopore Technologies plc (ONTTF) Stock

$1.53 +0.00% OTC: ONTTF Healthcare

Oxford Nanopore Technologies plc is dedicated to the development and commercialization of an innovative technology platform. This platform leverages nanopore-based sensing to facilitate the analysis of various types of molecules.

Valuation

MetricValue
Price$1.53
Market Cap$1.49B
P/E Ratio-7.57
P/B Ratio2.32
P/S Ratio4.87
EPS (TTM)$-0.15
52-Week High$3.34
52-Week Low$1.27
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-29.43%
ROA-23.33%
ROCE-30.78%
Gross Margin58.64%
Operating Margin-69.36%
Net Margin-64.85%
Debt/Equity0.09
Current Ratio3.56

Annual Financials (USD)

Metric20212022202320242025
Revenue$134.0M$199.0M$170.0M$183.0M$224.0M
Operating Profit$-165.0M$-98.0M$-169.0M$-152.0M$-128.0M
Net Profit$-168.0M$-91.0M$-155.0M$-146.0M$-145.0M
EPS$-0.20$-0.11$-0.19$-0.16$-0.15
Op Margin-123.1%-49.6%-99.4%-83.2%-57.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$842.0M$824.0M$777.0M$742.0M$622.0M
Total Liabilities$138.0M$130.0M$133.0M$156.0M$159.0M
Cash$488.0M$357.0M$221.0M$200.0M$181.0M
Borrowings$25.0M$34.0M$42.0M$46.0M$41.0M

Latest News

Global Next Generation Sequencing Services Market Size/Share Worth USD 56.1 Billion by 2035 at a 23.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis) GlobeNewswire · Jun 11, 2026 [Latest] Global Targeted DNA RNA Sequencing Market Size/Share Worth USD 46.9 Billion by 2035 at a 18.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) GlobeNewswire · May 4, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-54.0M$-49.0M$-137.0M$-110.0M$-63.0M
Investing Cash Flow$-193.0M$-108.0M$-89.0M$-34.0M$45.0M
Financing Cash Flow$-17.0M$-8.0M$-3.0M$-5.0M$-9.0M
Net Cash Flow$407.0M$-131.0M$-136.0M$-21.0M$-4.0M
Free Cash Flow$-85.0M$-92.0M$-165.0M$-159.0M$-66.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.46
EV / EBITDA-9.00
FCF Yield-4.14%
Quick Ratio2.87
Interest Coverage-55.46
Return 1Y-38.80%
Return 3Y-56.16%
Return 5Y

Ownership

Insiders Held43.18%
Institutions Held33.52%
Institutions Float Held58.99%
Institutional HolderSharesReport Date
Gilder, Gagnon, Howe & Co.125,9372023-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BRCTFBioArctic AB (publ) $31.78 -9.20% 125.73 $2.82B 2.61%
CSPHFCStone Pharmaceuticals $0.71 +0.00% -19.48 $1.14B 0.00%
GENSFGenus plc $31.07 +0.00% 30.03 $2.06B 0.97%
MEOBFMesoblast Limited $1.70 +0.00% -22.15 $2.20B 0.00%
NURPFNeuren Pharmaceuticals Limited $13.46 +0.00% 68.94 $1.71B 0.00%

About Oxford Nanopore Technologies plc

Oxford Nanopore Technologies plc is dedicated to the development and commercialization of an innovative technology platform. This platform leverages nanopore-based sensing to facilitate the analysis of various types of molecules. The company's product line includes several key devices: The MinION, a portable unit designed for sequencing deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The GridION, a self-contained benchtop instrument capable of operating and analyzing up to five MinION or Flongle flow cells. The MinION Mk1C, which integrates basecalling and data analysis, featuring a touchscreen interface and wireless connectivity. Flongle, an adapter that allows the use of Flongle flow cells with MinION or GridION devices. The GridION Mk1, another benchtop nanopore sequencer offered by the company. The PromethION 2 Solo and PromethION 2, providing an economical gateway to high-yield PromethION sequencing. Larger-scale needs are addressed by the PromethION 24 and PromethION 48 benchtop nanopore sequencers, which cater to multiple users for multi-sample and multi-experiment sequencing. VolTRAX, a USB-powered device that automates laboratory preparation steps prior to nanopore sequencing. In addition to hardware, Oxford Nanopore offers a suite of software solutions: MinKNOW, a software application for data acquisition, real-time analysis with feedback, local basecalling, and data streaming. Specialized Basecalling tools for identifying the sequence and type of bases in DNA/RNA molecules. EPI2ME, a cloud-based platform for comprehensive, real-time analysis of nanopore data. EPI2ME Labs, a bioinformatics resource designed to help users enhance their expertise and confidence in analyzing nanopore-based sequencing data. The company is also actively developing new products, including the MinION Mk1D, Ubi, Plongle, and SmidgION. Its products are available for purchase online. Established in 2005, the company was initially known as Oxford NanoLabs Limited before changing its name to Oxford Nanopore Technologies Limited in May 2008. Oxford Nanopore Technologies plc maintains its headquarters in Oxford, United Kingdom.

Oxford Nanopore Technologies plc is headquartered in GB.

Oxford Nanopore Technologies plc (ONTTF) stock trades at $1.53 with a market capitalization of $1.49B. The stock is valued at a price-to-earnings (P/E) ratio of -7.57, price-to-book of 2.32, price-to-sales of 4.87. Over the past 52 weeks the stock has ranged between $1.27 and $3.34, and currently trades 54.2% below its 52-week high.

On profitability, Oxford Nanopore Technologies plc generates a return on equity (ROE) of -29.43%, return on capital employed of -30.78%, an operating margin of -69.36%, a net profit margin of -64.85%.

Official website: nanoporetech.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides